Heterozygous de novo variants in the autophagy gene, WDR45, are found in betapropeller protein-associated neurodegeneration (BPAN). BPAN is characterized by adolescent onset dementia and dystonia; 66% patients have seizures. We asked whether WDR45 was associated with developmental and epileptic encephalopathy (DEE). We performed next generation sequencing of WDR45 in 655 patients with developmental and epileptic encephalopathies. We identified 3/655 patients with DEE plus 4 additional patients with de novo WDR45 pathogenic variants (6 truncations, 1 missense); all were female. Six presented with DEE and 1 with early onset focal seizures and profound regression. Median seizure onset was 12 months, 6 had multiple seizure types, and 5/7 had focal seizures. Three patients had magnetic resonance susceptibility-weighted imaging; blooming was noted in the globus pallidi and substantia nigra in the 2 older children aged 4 and 9 years, consistent with iron accumulation. We show that de novo pathogenic variants are associated with a range of developmental and epileptic encephalopathies with profound developmental consequences.
| INTRODUCTION
De novo pathogenic variants in the X-linked gene WDR45 are associated with a large spectrum of neurological diseases ranging from a specific form of neurodegeneration with brain iron accumulation, called betapropeller protein-associated neurodegeneration (BPAN 1 ; or static encephalopathy of childhood with neurodegeneration in adulthood [SENDA] 2 ) to isolated mild developmental delay (see Appendix S1). BPAN comprises the largest group, beginning with childhood developmental delay and evolving to progressive dystonia, dementia, and parkinsonism in late adolescence or early adulthood. Brain magnetic resonance imaging (MRI) shows iron deposition in the globus pallidus and substantia nigra, cerebral, and cerebellar atrophy. Two-thirds (37/56) of reported patients present with seizures, and at least 10 also had Rett-like features (see Appendix S1). Also, 3 males have been reported with West syndrome. 4 The developmental and epileptic encephalopathies (DEEs) are characterized by refractory seizures and frequent epileptiform activity that contribute to developmental slowing and often regression. Given that seizures occur frequently in patients with WDR45 diseases, we hypothesized that WDR45 pathogenic variants cause DEEs and sought to characterize the epilepsy phenotypes in WDR45 encephalopathy.
| MATERIALS AND METHODS
We recruited 655 patients with DEEs from our Australian epilepsy genetics research program and University of Washington. All patients had DEE according to ILAE classification criteria and did not have pathogenic variants in known DEE genes (unpublished data and Carvill et al. 5 ). An additional 59 Chinese patients with epilepsy
were screened who had a range of phenotypes. Written informed consent was obtained for all patients from their parents or legal guardians. The human research ethics committees of Austin Health, Peking University First Hospital, and University of Washington approved the study.
We performed targeted resequencing of WDR45 using molecular inversion probes (n = 655) or a customdesigned gene panel used in the Chinese cohort (n = 59) to capture all exons and 5 base pairs of flanking intronic sequence, using established protocols. 5, 6 We prioritized only variants that were nonsynonymous, altered the acceptor/donor splice sites, or were indels that disrupted the coding frame, and were not present in 65 000 individuals in ExAC (see Web Resources). We performed segregation analysis in parental DNA samples for all variants that met these criteria to determine whether they arose de novo. Two additional patients were ascertained by clinical testing; 1 with DEE had whole exome analysis (GeneDx) and 1 with intellectual disability (ID) and seizures underwent gene panel testing. 6 X-inactivation studies were performed in 5 patients to quantify the X-inactivation ratios; we assessed the variable number of tandem repeats, CAG repeats of the MAOA region, and human androgen receptor locus as described previously (with modifications). 7, 8 Briefly, 200 ng of DNA was digested with methylation-sensitive HhaI restriction enzyme; digested and undigested DNA were polymerase chain reaction amplified, and products were sized and quantified by capillary electrophoresis.
| RESULTS
We identified 7 de novo variants, all in girls (Table 1, Figure 1A) . Three of 655 (0.5%) individuals with DEE were identified by targeted resequencing, whereas 4 additional patients were found through collaborations. Six de novo variants resulted in a truncation (n = 1) or an indel (n = 5) predicted to cause a frameshift alteration. In 1 individual with intractable seizures and severe ID, we identified a de novo missense variant (Gly205Asp) in the third WD40 domain, at a highly conserved nucleotide (Genomic Evolutionary Rate Profiling 3.76, Combined Annotation Dependent Depletion [CADD] 21) predicted to be probably damaging by PolyPhen-2 (0.994) and damaging by Sorting Intolerant from Tolerant (SIFT; 0). X-inactivation studies revealed that inactivation was skewed in 1 female, mildly skewed in 1, and random in 2. A 5th case was uninformative, as she was homozygous for both polymorphisms (Table 1) .
Six patients had a range of DEEs, including 1 each with infantile spasms (IS), Lennox-Gastaut syndrome (LGS), IS evolving to LGS, and epilepsy with myoclonic-atonic seizures, and 2 with unclassified DEE. One patient did not have a DEE; she had a history of 8 focal seizures with fever and severe regression with seizure onset at 1 year, following isolated speech delay.
Median seizure onset was 12 months (range = 7-36). Focal impaired awareness seizures occurred in 5/7 patients. Six developed multiple seizure types including tonic seizures, spasms (Video S1), and focal, absence, and myoclonic seizures. Seizures were refractory to virtually all antiepileptic drugs; 2 individuals were on no drugs.
All patients showed developmental delay prior to seizure onset ( speech in all 5 patients, loss of smiling and reduced eye contact in 1 patient, loss of sitting and rolling over in 1 patient, and less response to painful stimuli in 1 patient. Regression coincided with seizure onset in 4 patients. Information gathered from examinations by neurologists and pediatricians and from direct questioning of parents identified 2 patients with profound impairment who were nonverbal and could not sit, 4 patients with severe impairment who had few single words but could walk, and the youngest patient at age 2 years with global developmental delay; she was nonverbal but could eat with a spoon and pull herself to stand but not walk independently. The 2 Chinese patients underwent formal developmental assessments; patient 5 was assessed at chronological age 7 years to be at a developmental age of 3 years for fine and gross motor skills, 16 months for language skills, and e10 | 3 years for social skills. Patient 6 was assessed at chronological age 4 years to be at a developmental age of 3 years for fine motor skills and 19.5 months for language skills. Neurological examination revealed generalized spasticity in 2 (Video S1). Typical hand stereotypies of Rett syndrome seen in patients with BPAN were not observed in any of our patients. Six patients had 12 brain MRI studies. Median age at first MRI was 17 months (range = 7 months to 9 years). Five of 6 children had a structurally normal brain with thin corpus callosum, ventriculomegaly (3 mild, 2 moderately severe with frontal predominance), and prominent frontal extra-axial cerebrospinal fluid spaces. White matter volume loss with normal myelination was present in 2/6, and severe progressive atrophy associated with severely delayed myelination occurred in 2/6 ( Figure 1B) . Two patients developed mild cerebellar atrophy and 1 increased T2 signal. Hippocampi could be evaluated in 5/6 cases, as 1 had no coronal imaging. Four of 5 had dysplastic, small hippocampi with loss of normal internal architecture. Of the 3 children with susceptibility sequences (susceptibilityweighted imaging [SWI]), 2 had marked blooming in the globus pallidi and substantia nigra. The youngest patient had normal SWI at 7 months. Patient 5, whose scan was normal at 2 and 3 years, showed mild cerebellar atrophy at 5 years.
| DISCUSSION
We expand the phenotypic spectrum of WDR45 encephalopathy to include DEEs characterized by regression with seizure onset resulting in severe to profound impairment. Our cohort showed infantile onset of regression in 5 patients, associated with seizure onset at age 7 to 17 months in 4 and with escalating seizures in the remaining child. Patient 4, aged 2 years, has shown a plateau in development, and Patient 7 has severe intellectual disability at 3 years. The importance of this early onset regression is further highlighted by Patient 6, who regressed from isolated speech delay to severe intellectual disability at age 1 year with seizure onset. Individuals with BPAN/SENDA show mild delay in childhood and regress later in adolescence or adult life, 3 contrasting significantly with the regression and severe disability early in life in WDR45 DEE. There is no obvious genotype-phenotype correlation with respect to pathogenic variant type or location to explain our patients' early regression ( Figure 1A ). Two patients with West syndrome and refractory seizures had a premature truncation at positions 210 and 221, yet 3 patients with isolated mild delay had truncating variants just several amino acids away at positions 196 (n = 2) and 213. 2, 9 Our only patient with a missense variant had variant onset at 36 months, much later than the 6 individuals with truncations (median onset = 12 months). Further analysis of seizure onset in patients with missense variants is required to establish whether this correlation is significant. Only 8 males have been reported with WDR45 pathogenic variants, including 3 with West syndrome and truncation mutations. 4 A boy with an Xp11.23 microdeletion, including WDR45, has a more severe early onset DEE with onset of spasms and focal seizures at F I G U R E 1 A, Distribution of all 63 novel and published WDR45 pathogenic variants reported previously and in this study (in red). The majority of pathogenic variants occur in females, with only 8 males (in blue) described; the WD40 domains are shown in pink. Upper panel of the schematic shows all pathogenic variants in patients in whom seizures are not present, whereas those variants in the lower panel show those individuals who had seizures. Gray circles within the protein sketch represent missense variants that are present more than once in the ExAC dataset containing whole exome data from~65 000 individuals. Eighty-four percent (52/63) of pathogenic variants are either known or thought to lead to truncation of WDR45, suggesting a loss-of-function mechanism. Only 7 missense variants and 3 single amino acid in-frame deletions have been reported, including the G205D variant reported here. Five of 7 missense variants fall within the WD40 domains, and these regions tend to be devoid of missense variation in the general population, suggesting that these missense pathogenic variants likely lead to a loss of function of the WD40 domains. B, (a-f), Magnetic resonance imaging ( 3 months and profound impairment from birth. 10 Males seem to have a more severe phenotype, or are proposed to have somatic mosaic variants, 1, 4 suggesting that pathogenic variants in WDR45 are lethal, or more severe in hemizygous males. However, we also describe girls with a severe phenotype. Skewing of X-inactivation toward the mutated allele has been proposed to explain this phenotypic variability. 2 To date, 17/19 females with BPAN and pathogenic WDR45 variants have skewed X-inactivation. Only 1 of our patients with West syndrome and a truncation had skewed X-inactivation (Table 1) . Given these figures, X-inactivation cannot be the sole explanation for the phenotypic spectrum associated with WDR45 pathogenic variants; therefore, additional genetic or environmental factors may underlie this phenotypic variability. However, whether skewing patterns in the blood reflect those in the brain is unknown; different cerebral patterns of X-inactivation could explain the WDR45 phenotypic spectrum. Two patients had severe spasticity with truncal hypotonia, associated with relatively little movement (Video S1). The lack of a movement disorder separates their phenotype from genetic DEEs associated with SCN2A, SCN8A, and STXBP1 mutations, 11 and other encephalopathies such as
Rett syndrome. Although adults with pathogenic variants in WDR45 have a distinct imaging phenotype, this was not seen in our patients. Adults with BPAN have T1 hyperintensity of the peduncles, substantia nigra, and to a lesser extent, the globus pallidi. 3, 12 These regions may show T2/fluidattenuated inversion recovery (FLAIR) hypointensity corresponding to iron deposition. None of our cohort had T2 hypointensity in the globus pallidi, although 2, aged 4 and 9 years, had blooming on SWI, which likely represents iron deposition. The youngest reported case with T2 hypointensity in the globus pallidi was an 11-yearold girl, 13 and our oldest patient last had imaging performed at 10 years and 5 months, so this may yet evolve. Our MRI findings are similar to those reported in adults, including atrophy, thin corpus callosum, delayed myelination, and large ventricles consistent with white matter volume loss. 14, 15 Two had severe progressive atrophy, with prominent frontal lobe involvement, and delayed myelination. Hippocampal appearances have not been described previously; 4/5 (67%) patients had hippocampal malformations, including our youngest patient. Small, dysplastic, and malrotated hippocampi with loss of normal internal architecture are developmental abnormalities, quite distinct from hippocampal sclerosis. We expand the phenotypic spectrum of WDR45 disorders to include infantile presentations with DEEs with abnormal early development, early seizure onset, multiple seizure types, regression, and severe to profound impairment. Importantly, the MRI findings of brain iron accumulation associated with BPAN were not visible on FLAIR/ T2 sequences in the first decade; however, the more sensitive SWI sequence showed blooming at 4 and 9 years of age but not in early life. Thus, a normal MRI should not preclude consideration of WDR45 testing in patients with DEEs. 
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